Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Inovio Pharmaceuticals Primed For a Comeback?

TheMotleyFool

0 0

Is Inovio Pharmaceuticals Primed For a Comeback?Photo, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png

It seems like a long time ago that Inovio Pharmaceuticals (NASDAQ: INO) was considered a leader in the race to develop an effective coronavirus vaccine. The biotech was soundly defeated in that competition, and while it is trying to play catch up, other players have already racked up billions in sales from their vaccines.

Unsurprisingly, investors mostly gave up on Inovio, and its shares have lost more than half their value in the past 12 months. But some recent developments could help Inovio stage a rebound -- and if it does, its shares would be a steal at current levels. Can Inovio pull off a comeback?